CA1332808C - Composition a base de polyester pour la liberation controlee de substances medicinales - Google Patents

Composition a base de polyester pour la liberation controlee de substances medicinales

Info

Publication number
CA1332808C
CA1332808C CA000579976A CA579976A CA1332808C CA 1332808 C CA1332808 C CA 1332808C CA 000579976 A CA000579976 A CA 000579976A CA 579976 A CA579976 A CA 579976A CA 1332808 C CA1332808 C CA 1332808C
Authority
CA
Canada
Prior art keywords
polyester
polypeptide
composition according
diol
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000579976A
Other languages
English (en)
Inventor
Peter Speiser
Urs Schleuniger
Piero Orsolini
Frederic Heimgartner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Debio Recherche Pharmaceutique SA
Original Assignee
Debiopharm SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm SA filed Critical Debiopharm SA
Application granted granted Critical
Publication of CA1332808C publication Critical patent/CA1332808C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA000579976A 1987-10-14 1988-10-13 Composition a base de polyester pour la liberation controlee de substances medicinales Expired - Fee Related CA1332808C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4022/87 1987-10-14
CH4022/87A CH672887A5 (fr) 1987-10-14 1987-10-14

Publications (1)

Publication Number Publication Date
CA1332808C true CA1332808C (fr) 1994-11-01

Family

ID=4268357

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000579976A Expired - Fee Related CA1332808C (fr) 1987-10-14 1988-10-13 Composition a base de polyester pour la liberation controlee de substances medicinales

Country Status (14)

Country Link
JP (1) JP2716747B2 (fr)
BE (1) BE1001687A5 (fr)
CA (1) CA1332808C (fr)
CH (1) CH672887A5 (fr)
DE (1) DE3835099A1 (fr)
DK (1) DK571488A (fr)
ES (1) ES2009347A6 (fr)
FR (1) FR2622105B1 (fr)
GB (1) GB2211091B (fr)
GR (1) GR1000266B (fr)
IE (1) IE60475B1 (fr)
IT (1) IT1227394B (fr)
NL (1) NL8802490A (fr)
PT (1) PT88757B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU221294B1 (en) * 1989-07-07 2002-09-28 Novartis Ag Process for producing retarde compositions containing the active ingredient in a polymeric carrier
CH681425A5 (fr) * 1990-11-14 1993-03-31 Debio Rech Pharma Sa
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
ZA936692B (en) * 1992-09-12 1994-04-29 Dott Ltd Comp Physiologically active peptide composition
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
FR2777895A1 (fr) * 1998-04-28 1999-10-29 Debio Rech Pharma Sa Polymere sequence non-reticule,procede pour sa preparation, et ses utilisations
WO2004108792A2 (fr) * 2003-04-10 2004-12-16 Vinod Chintamani Malshe Nouveaux polyesters aliphatiques biodegradables, nouvelles compositions pharmaceutiques et leurs applications

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978203A (en) * 1974-07-12 1976-08-31 Dynatech Corporation Sustained release of pharmaceuticals from polyester matrices
DE2856901D2 (de) * 1977-06-07 1980-11-13 Garching Instrumente Form of implant medicament and preparation process
US4186189A (en) * 1977-09-28 1980-01-29 Ethicon, Inc. Absorbable pharmaceutical compositions based on poly(alkylene oxalates)
US4130639A (en) * 1977-09-28 1978-12-19 Ethicon, Inc. Absorbable pharmaceutical compositions based on isomorphic copolyoxalates
US4594407A (en) * 1983-09-20 1986-06-10 Allied Corporation Prosthetic devices derived from krebs-cycle dicarboxylic acids and diols
US4481353A (en) * 1983-10-07 1984-11-06 The Children's Medical Center Corporation Bioresorbable polyesters and polyester composites

Also Published As

Publication number Publication date
GB2211091A (en) 1989-06-28
NL8802490A (nl) 1989-05-01
DE3835099A1 (de) 1989-04-27
JPH01157920A (ja) 1989-06-21
DK571488A (da) 1989-04-15
GB2211091B (en) 1991-02-13
CH672887A5 (fr) 1990-01-15
FR2622105B1 (fr) 1993-05-14
DK571488D0 (da) 1988-10-13
ES2009347A6 (es) 1989-09-16
BE1001687A5 (fr) 1990-02-06
GR1000266B (el) 1992-05-12
PT88757B (pt) 1993-01-29
GB8823735D0 (en) 1988-11-16
IE883110L (en) 1989-04-14
FR2622105A1 (fr) 1989-04-28
JP2716747B2 (ja) 1998-02-18
IT1227394B (it) 1991-04-08
IE60475B1 (en) 1994-07-13
IT8805224A0 (it) 1988-10-11

Similar Documents

Publication Publication Date Title
CA1100041A (fr) Composes pharmaceutiques absorbables a base de copolyoxalates isomorphiques
US5187150A (en) Polyester-based composition for the controlled release of polypeptide medicinal substances
KR100303681B1 (ko) 수용성펩티드의서방성제제
FI80284C (fi) Farmaceutiskt eller veterinaert godtagbar amfipatisk blocksampolymer och dess framstaellning.
CA2040141C (fr) Polymeres biodegradables a haute densite moleculaire production et utilisation desdits polymeres
KR100422391B1 (ko) 용융공정에의해펩티드를포함하는생분해가능한미소구의제조
CA2196698C (fr) Polyesters
US4801739A (en) Oligomeric hydroxycarboxylic acid derivatives, their production and use
US4186189A (en) Absorbable pharmaceutical compositions based on poly(alkylene oxalates)
JPH05271051A (ja) ポリ（ラクチド−共−グリコリド）ポリマーの製造法
JP3834331B2 (ja) 表面活性剤を含有しない生体再吸収性重合体微小球、その製造及び薬剤としてその応用
CA1332808C (fr) Composition a base de polyester pour la liberation controlee de substances medicinales
CN114761463A (zh) 可生物降解的相分离的热塑性多嵌段共聚物
JPH04218528A (ja) 生体内分解型高分子重合物
US20060286138A1 (en) Novel biodegradable aliphatic polyesters and pharmaceutical compositions and applications thereof
JP2001192439A (ja) 生体内分解型高分子重合物
JP3663271B2 (ja) 新規の分枝鎖エステル及びその製法
KR100356737B1 (ko) 폴리에스테르의제조방법
CZ278181B6 (en) Process of purifying polymers and oligomers of aliphatic hydroxy- acids

Legal Events

Date Code Title Description
MKLA Lapsed